Meet Anita Ying, M.D.
Anita K. Ying, M.D., M.B.A.
Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine
About Dr. Ying
Anita Ying, M.D., M.B.A. is a Professor in Endocrinology and Pediatric Endocrinology at UT MD Anderson Cancer Center. She received her B.A. in Sociology from Rice University and her M.D. from Duke University. She completed a residency in Internal Medicine/Pediatrics at Duke and a fellowship in Adult and Pediatric Endocrinology at Baylor College of Medicine and MD Anderson Cancer Center. She joined MD Anderson as faculty in 2008. She completed her Executive MBA with Healthcare specialization at Rice University in May 2013, and received the Jones Scholar Award. Dr. Ying provides clinical care as the primary oncologic endocrinologist for children and adults with endocrine tumors, such as thyroid cancer, pituitary tumors, and genetic endocrine tumor syndromes. She also sees MD Anderson cancer patients who develop endocrine complications from their cancer treatment. Dr. Ying believes in the importance of patients and their families participating in treatment decisions as a partnership with their provider teams.As Vice President, Ambulatory Medical Operations, she oversees with her administrative partner the clinical operations of the outpatient enterprise on the Texas Medical Center campus and the Houston Area Locations. Dr. Ying strives to create a safe, high-quality, and streamlined experience for patients, staff, and providers. Dr. Ying serves on the board for the San Jose Clinic, a safety net clinic that provides medical, dental, and pharmacy care for the uninsured. She has written numerous book chapters, articles, and clinical reviews on the care for adults and children with inherited endocrine tumor syndromes and thyroid cancer.
Read More
Present Title & Affiliation
Primary Appointment
Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Pediatrics, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Vice President, Ambulatory Medical Operations, Department of Office of the Chief Operating Officer, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2013 | Rice University, Jesse H. Jones Graduate School of Business, Houston, Texas, US, MBA in Healthcare Specialization |
| 1999 | Duke University School of Medicine, Durham, North Carolina, US, MD |
| 1994 | Rice University, Houston, Texas, US, BA in Sociology |
Postgraduate Training
| 2021-2021 | Certification, CoachRice Leadership Coach, Rice University Doerr Institute of Leaders, Houston, Texas |
| 2004-2008 | Clinical Fellowship, Adult and Pediatric Endocrinology, Baylor College of Medicine and The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2000-2003 | Clinical Residency, Internal Medicine and Pediatrics, Duke University Medical Center, Durham, North Carolina |
| 1999-2000 | Clinical Internship, Internal Medicine and Pediatrics, Duke University Medical Center, Durham, North Carolina |
Board Certifications
| 2009 | Pediatric Endocrinology |
| 2008 | Endocrinology, Diabetes, and Metabolism |
Experience & Service
Academic Appointments
Associate Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2021
Associate Professor, Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2021
Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2015
Assistant Professor, Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2015
Co-Chief Resident and Associate in Pediatrics, Duke University Medical Center, Durham, NC, 2003 - 2004
Assistant Chief Resident in Internal Medicine, Duke University Medical Center, Durham, NC, 2002 - 2002
Administrative Appointments/Responsibilities
Endocrine Center Patient Experience Officer, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2018
Executive Medical Director, Department of Ofc/EVP, Physician-in-Chief, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2018
Faculty Executive Partner, Clinical Operations Leadership Team, Department of Ofc/EVP, Physician-in-Chief, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2015
Clinical Medical Director, Department of Endocrine Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2018
Quality Officer, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2018
Co-Quality Officer, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2011
Other Appointments/Responsibilities
Member, Advisory Board, San Jose Clinic, Houston, Texas, 2021 - Present
Chair, Student Engagement Committee, Rice Business Partners Board, Houston, TX, 2018 - 2020
One Connect/EPIC SuperUser, UT MD Anderson Cancer Center, Houston, TX, 2015 - 2018
Member, Rice Business Partners Board, Houston, TX, 2015 - 2021
Chair, Program Services Board Committee, San Jose Clinic, Houston, TX, 2013 - 2020
Adjunct Faculty Member, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX, 2011 - 2012
Member, Board of Directors, The Stanley J. Sarnoff Endowment for Cardiovascular Science, Great Falls, VA, 2010 - 2011
Chair, Alumni Committee, The Stanley J. Sarnoff Cardiovascular Research Foundation, Great Falls, VA, 2009 - 2012
Member, Fellowship Selection Committee, Baylor College of Medicine Endocrine Fellowship Program, Houston, TX, 2008 - 2019
Provider Leader, Clinic Call System Committee, Baylor College of Medicine, Division of Pediatric Endocrinology/Metabolism, Houston, TX, 2006 - 2008
House staff Elected Representative, Internal Committee on Graduate Medical Education, Duke University Medical Center, Durham, NC, 2001 - 2003
House staff Elected Representative, Duke University Medical Center, Executive Committee of Medical Staff, Houston, TX, 2001 - 2003
Member, Scientific Board, The Stanley J. Sarnoff Endowment for Cardiovascular Science, Columbus, OH, 1998 - 2000
Institutional Committee Activities
Member, REACH Executive Committee, 2022 - Present
Member, Care Team Transformation Steering Committee, 2021 - Present
Member, Access Redesign Oversight Committee, 2021 - Present
Voting Member, Virtual Care & Access Executive Committee, 2020 - 2022
Voting Member, COVID Core Leadership Team (CCLT), 2020 - Present
Voting Member, Quality Assessment - Performance Improvement Council (QAPI), 2019 - Present
Voting Member, Strategic Innovation Informatics, 2019 - 2020
Rotating Incident Commander, Incident Command Team, 2019 - Present
Member, Medical Practice Quality Planning Committee, ECMS, 2019 - 2019
Steering Team Member, Clinical Operations Leadership Team (COLT), 2018 - 2019
Member, Radiation Physics Chair Search Committee, 2018 - 2019
Member, Operational Priority #1 - Patient Experience, 2017 - 2018
Member, Operational Priority #5 - Information Systems, 2017 - 2020
Member, Faculty Health and Well-Being, 2017 - 2018
Member of Leadership Council overseeing Leadership Institute, Operational Priority - Recruitment, Retention, Development, 2017 - Present
Member, Steering and Strategy Reporting Metrics Committee, 2017 - Present
Member, Data Analytics Reporting Informatics Committee, 2017 - 2019
Member, Executive Clinical Operations Team (ECOT), 2016 - 2017
Co-Chair, Integrated Practice Committee, 2016 - 2017
Member, Ambulatory Informatics Committee, 2016 - Present
Member, Patient Care Informatics Committee, 2016 - Present
Co-Chair, Ambulatory Practice Committee, 2015 - 2017
Faculty Sponsor, Financial Clearance Center Steering Committee, 2015 - 2017
Member, Real-time Locating System (RTLS) Strategic Initiative, 2015 - 2018
Co-Leader, Patient Access Strategic Steering Committee, 2014 - 2017
Member, Patient Experience Steering Committee, 2014 - 2016
Faculty Leader, Procedural Software Leadership Team, 2014 - 2017
Faculty Leader, Time Driven Activity Based Costing Software Team, 2014 - 2016
Member, One Connect/EPIC Integrated Clinical Team, 2014 - 2016
Member, Scheduling Committee-Delays Workgroup, 2014 - 2015
Member, eCSR Implementation Team, 2013 - 2015
Member, Faculty Recognition Plan Work Group, 2013 - 2014
Faculty Associate, Institute for Cancer Care Innovation, 2013 - Present
Co-Chair, Radioactive Iodine Operations Work Group, 2013 - 2014
Member, ePrescribe Renewal EHR Subcommittee, 2013 - 2013
Member, Inpatient Hypoglycemia Management Work Group, 2013 - 2014
Chair, Endocrine Center Steering Committee, 2012 - 2018
Member, Soarian Project Operational Leadership Team, 2012 - 2012
Member, On-Call System Steering Committee, 2012 - Present
Member, Endocrine Center Steering Committee, 2011 - 2012
Co-Chair, Strategic Assessment of Clinical Programs Steering Committee, 2011 - 2013
Member, Endocrine Clinical Practice Committee, 2011 - 2018
Member, Expense Analysis Clinical Operations Subcommittee, 2011 - 2011
Member, Physician Relations Advisory Board, 2011 - Present
Member, Clinical Faculty Incentive Work Group, 2010 - 2011
Member, Clinical Effectiveness Medical Affairs Subcommittee, 2010 - 2013
Member, Physician Communications Initiative, 2010 - 2014
Member, Institutional Pilot for New Inpatient Consult Notification, 2010 - 2012
Chair, Task Force to Revise New Patient Scheduling Process in the Endocrine Center, 2009 - 2012
Member, Division of Internal Medicine Quality Council, 2008 - 2013
Honors & Awards
| 2023 | Beta Gamma Sigma Business Honor Society, Association to Advance Collegiate School of Business |
| 2022 | Beta Gamma Sigma Business Honor Society, Association to Advance Collegiate School of Business |
| 2021 | Beta Gamma Sigma Business Honor Society, Association to Advance Collegiate School of Business |
| 2021 | Perfect Score Provider CG-CAHPS Patient Satisfaction |
| 2020 | Beta Gamma Sigma Business Honor Society, Association to Advance Collegiate School of Business |
| 2020 | Perfect Score Provider CG-CAHPS Patient Satisfaction |
| 2020 | Perfect Score Provider CG-CAHPS Patient Satisfaction |
| 2019 | Patient Access Collaborative Award of Excellence, Patient Access Collaborative |
| 2019 | Beta Gamma Sigma Business Honor Society, Association to Advance Collegiate School of Business |
| 2019 | Perfect Score Provider CG-CAHPS Patient Satisfaction |
| 2018 | Top 1% Providers in CG-CAHPS Patient Satisfaction |
| 2018 | Beta Gamma Sigma Business Honor Society, Association to Advance Collegiate School of Business |
| 2017 | Beta Gamma Sigma Business Honor Society, Association to Advance Collegiate School of Business |
| 2017 | Top 1% Providers in CG-CAHPS Patient Satisfaction |
| 2016 | Beta Gamma Sigma Business Honor Society, Association to Advance Collegiate School of Business |
| 2015 | Beta Gamma Sigma Business Honor Society, Association to Advance Collegiate School of Business |
| 2014 | Beta Gamma Sigma Business Honor Society, Association to Advance Collegiate School of Business |
| 2013 | Jones Scholar Award, Rice University Jesse H. Jones Graduate School of Business |
| 2013 | Beta Gamma Sigma Business Honor Society, Association to Advance Collegiate School of Business |
| 2012 | Beta Gamma Sigma Business Honor Society, Association to Advance Collegiate School of Business |
| 2007 | Genentech Clinical Fellows Travel Grant |
| 2006 | Genentech Clinical Fellows Travel Grant |
| 1997 | Four Schools Physician-Scientist Fellowship |
| 1997 | The Stanley J. Sarnoff Cardiovascular Scientific Science Fellowship |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Castellanos LE, Zafereo ME, Sturgis EM, Wang JR, Ying AK, Waguespack SG. Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine. J Clin Endocrinol Metab None(None):None, 2024. PMID: 39163248.
- Torres, HA, Mustafayev, K, Juneau, RP, Hwang, JP, Wang, LS, Angelidakis, G, Hawk, E, Granwehr, BP, Yepez Guevara, E, Ying, AK. Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center. JNCCN Journal of the National Comprehensive Cancer Network 22(2D), 2024. PMID: 38729204.
- Hensley SG, Hu MI, Bassett RL, Ying AK, Zafereo ME, Perrier ND, Busaidy NL, Hyde SM, Grubbs EG, Waguespack SG. Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-term Outcomes in 144 Patients Over Six Decades. J Clin Endocrinol Metab None(None):None. e-Pub 2024. PMID: 38441533.
- Torres HA, Mustafayev K, Juneau R, Hwang JP, Wang LS, Angelidakis G, Hawk E, Granwehr BP, Yepez Guevara E, Ying AK. Implementation of Universal Hepatitis C Virus Screening in a Tertiary Care Cancer Center. JNCCN None(None):None. e-Pub 2023. PMID: None.
- Cabanillas ME, Dadu R, Iyer P, Wanland KB, Busaidy NL, Ying A, Gule-Monroe M, Wang JR, Zafereo M, Hofmann MC. Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors. Thyroid 30(9):1288-1296, 2020. e-Pub 2020. PMID: 32216548.
- Berkman AM, Livingston JA, Merriman K, Hildebrandt M, Wang J, Dibaj S, McQuade J, You N, Ying A, Barcenas C, Bodurka D, DePombo A, Lee HJ, de Groot J, Roth M. Long-term survival among 5-year survivors of adolescent and young adult cancer. Cancer 126(16):3708-3718, 2020. e-Pub 2020. PMID: 32484922.
- Triche L, Yarbrough A, Roth M, Ying A, Wells R. Sustained molecular response following a failed attempt of tyrosine kinase inhibitor discontinuation & the effects on growth in a child with chronic myeloid leukemia: not always a short story. Pediatr Hematol Oncol 37(5):375-379, 2020. e-Pub 2020. PMID: 32347770.
- Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head Neck 42(6):1325-1328, 2020. e-Pub 2020. PMID: 32437031.
- Morani A, Waguespack SG, Bhosale H, Ying AK. Steroid Cell Ovarian Tumor in a Case of Von Hippel-Lindau Disease: Demonstrating lipid Content of the Mass on MRI. Magnetic Resonance in Medical Sciences 18(4):251-252, 2019. PMID: 30700659.
- Romero Arenas MA, Rich TA, Hyde SM, Busaidy NL, Cote GJ, Hu MI, Gagel RF, Gidley PW, Jimenez C, Kupferman ME, Peterson SK, Sherman SI, Ying A, Bassett RL, Waguespack SG, Perrier ND, Grubbs EG. Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. Ann Surg Oncol 25(5):1395-1402, 2018. e-Pub 2018. PMID: 29427212.
- Cabanillas ME, Williams MD, Gunn GB, Weitzman SP, Burke L, Busaidy NL, Ying AK, Yiin YH, William WN, Lu C, Lai SY. Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer. Head Neck 39(7):1291-1295, 2017. e-Pub 2017. PMID: 28452157.
- Xu JY, Murphy WA, Milton DR, Jimenez C, Rao SN, Habra MA, Waguespack SG, Dadu R, Gagel RF, Ying AK, Cabanillas ME, Weitzman SP, Busaidy NL, Sellin RV, Grubbs E, Sherman SI, Hu MI. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. J Clin Endocrinol Metab 101(12):4871-4877, 2016. e-Pub 2016. PMID: 27662441.
- Dadu R, Hu MI, Cleeland C, Busaidy NL, Habra M, Waguespack SG, Sherman SI, Ying A, Fox P, Cabanillas ME. The efficacy of the natural clay, Calcium Aluminosilicate Anti-Diarrheal (CASAD), in reducing medullary thyroid cancer-related diarrhea and its effects on quality of life: a pilot study. Thyroid 25(10):1085-90, 2015. e-Pub 2015. PMID: 26200040.
- Lairmore TC, Diesen D, Goldfarb M, Milas M, Ying AK, Sharma J, McIver B, Wong RJ, Randolph G, Scientific Committee AES. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: TIMING OF MULTIPLE ENDOCRINE NEOPLASIA THYROIDECTOMY AND EXTENT OF CENTRAL NECK LYMPHADENECTOMY. Endocr Pract 21(7):839-47, 2015. PMID: 26172129.
- Dadu R, Shah K, Busaidy NL, Waguespack SG, Habra MA, Ying AK, Hu MI, Bassett R, Jimenez C, Sherman SI, Cabanillas ME. Efficacy and Tolerability of Vemurafenib in Patients with BRAFV600E -Positive Papillary Thyroid Cancer: M.D. Anderson Cancer Center Off Label Experience. J Clin Endocrinol Metab 100(1):E77-81, 2015. PMID: 25353071.
- Feng L, Busaidy N, Cote GJ, Gagel RF, Hu MI, Jimenez C, Lee JE, Perrier N, Sherman SI, Waguespack SG, Ying AK, Grubbs EG. Prevalence by Age and Predictors of Medullary Thyroid Cancer in Patients with Lower Risk Germline RET Proto-Oncogene Mutations. Thyroid 24(7):1096-106, 2014. e-Pub 2014. PMID: 24617864.
- Dadu R, Devine C, Hernandez M, Waguespack SG, Busaidy NL, Hu MI, Jimenez C, Habra MA, Sellin RV, Ying AK, Cote GJ, Sherman SI, Cabanillas ME. Role of Salvage Targeted Therapy in Differentiated Thyroid Cancer Patients Who Failed First-Line Sorafenib. J Clin Endocrinol Metab 99(6):2086-94, 2014. e-Pub 2014. PMID: 24628550.
- Dadu R, Waguespack SG, Sherman SI, Hu MI, Busaidy NL, Jimenez C, Habra MA, Ying AK, Bassett RL, Cabanillas ME. Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients with Differentiated Thyroid Cancer. Oncologist 19(5):477-82, 2014. e-Pub 2014. PMID: 24733667.
- Cooper AB, Habra MA, Grubbs EG, Bednarski BK, Ying AK, Perrier ND, Lee JE, Aloia TA. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma?. Surg Endosc 27(11):4026-32, 2013. e-Pub 2013. PMID: 23765427.
- Carhill AA, Cabanillas ME, Jimenez C, Waguespack SG, Habra MA, Hu M, Ying A, Vassilopoulou-Sellin R, Gagel RF, Sherman SI, Busaidy NL. The Noninvestigational Use of Tyrosine Kinase Inhibitors in Thyroid Cancer: Establishing a Standard for Patient Safety and Monitoring. J Clin Endocrinol Metab 98(1):31-42, 2013. e-Pub 2012. PMID: 23185034.
- Morris LF, Waguespack SG, Edeiken-Monroe BS, Lee JE, Rich TA, Ying AK, Warneke CL, Evans DB, Perrier ND, Grubbs EG. Ultrasonography Should Not Guide the Timing of Thyroidectomy in Pediatric Patients Diagnosed with Multiple Endocrine Neoplasia Syndrome 2A through Genetic Screening. Ann Surg Oncol 20(1):53-9, 2013. e-Pub 2012. PMID: 22890595.
- Morris LF, Waguespack SG, Warneke CL, Ryu H, Ying AK, Anderson BJ, Sturgis EM, Clayman GL, Lee JE, Evans DB, Grubbs EG, Perrier ND. Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy. Surgery 152(6):1165-71, 2012. PMID: 23158186.
- Ejaz S, Vassilopoulou-Sellin R, Busaidy NL, Hu MI, Waguespack SG, Jimenez C, Ying AK, Cabanillas M, Abbara M, Habra MA. Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience. Cancer 117(19):4381-9, 2011. e-Pub 2011. PMID: 21412758.
- Ying AK, Lairson DR, Giardino AP, Bondy ML, Zaheer I, Haymond MW, Heptulla RA. Predictors of direct costs of diabetes care in pediatric patients with type 1 diabetes. Pediatr Diabetes 12(3 Pt 1):177-82, 2011. e-Pub 2010. PMID: 20807368.
- Grubbs EG, Waguespack SG, Rich TA, Xing Y, Ying AK, Evans DB, Lee JE, Perrier ND. Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?. Surgery 148(6):1302-10, 2010. PMID: 21134565.
- Jasim S, Ying AK, Waguespack SG, Rich TA, Grubbs EG, Jimenez C, Hu MI, Cote G, Habra MA. Multiple Endocrine Neoplasia Type 2B with a RET Proto-Oncogene A883F Mutation Displays a More Indolent Form of Medullary Thyroid Carcinoma Compared with a RET M918T Mutation. Thyroid 21(2):189-92. e-Pub 2010. PMID: None.
- Ying AK, Hassanain HH, Roos CM, Smiraglia D, Issa JP. Methylation of the Estrogen Receptor-alpha Gene Promoter is Selectively Increased in proliferating human aortic smooth Muscle Cells. Cardiovascular Research 46:172-79, 2000. PMID: None.
- Moldovan NI, Qian Z, Chen Y, Dong C, Ying AK. Fas-mediated apoptosis in accelerated graft arteriosclerosis. Angiogenesis 2:245-54, 1998. PMID: None.
Invited Articles
- Ying AK, Feeley TW, Porter ME. Valued-based healthcare:Implications for Thyroid Cancer. International Journal of Endocrine Oncology 3(2):115-129, 2016. PMID: None.
- Hu MI, Ying AK, Jimenez C. Update on Medullary Thyroid Cancer. Endocrinol Metab Clin North Am 43(2):423–442, 2014. PMID: 24891170.
- Ying AK, Huh W, Bottomley S, Evans D, Waguespack S. Thyroid Cancer in Young Adults. Semin Oncol 36(3):258-74, 2009. PMID: 19460583.
Other Articles
- Cohen AB, Stump L, Krumholz HM, Cartiera M, Jain S, Sussman LS, Hsiao A, Lindop W, Ying AK, Kaul RL, Balcezak TJ, Tereffe W, Comerford M, Jacoby D, Navai N Aligning mission to digital health strategy in academic medical centers. NPJ Dig Med 5(67):8, 2022. PMID: 35654885.
- Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 95(5):2023-37, 2010. PMID: 20215394.
Book Chapters
- Waguespack SG, Ying AK. Pheochromocytoma and Multiple Endocrine Neoplasia Syndromes. In: Pediatric Endocrinology. 4th. None, 2014.
- Waguespack SG, Bauer AJ, Huh W, and Ying AK. Endocrine Tumors. In: Principles and Practice of Pediatric Endocrinology. 6th. Lippincott Williams and Wilkins, 2010.
Patient Reviews
CV information above last modified November 11, 2024